{
  "prompt": {
    "guidelineId": "gp003-pelvic-inflammatory-disease-pid-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 3207
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Pelvic Inflammatory Disease Management Protocol\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"NICE\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"2004\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Pelvic Inflammatory Disease (PID) Protocol: GP003** **Definition & Epidemiology**: PID is an ascending infection from the endocervix, causing inflammation of pelvic organs. Incidence is likely underestimated and increasing due to rising STIs. **Pathogens**: Commonly caused by *Chlamydia trachomatis*, *Neisseria gonorrhoeae*, anaerobes, and *Mycoplasma*. **Diagnosis**: - Clinical features: Lower abdominal pain, dyspareunia, abnormal bleeding/discharge, tenderness, fever. - Testing: Screen for gonorrhoea/chlamydia; consider urinalysis, blood tests, swabs, and pelvic ultrasound. **Management**: - **Antibiotics**: Broad-spectrum regimens (outpatient or inpatient), adjusted for pregnancy and penicillin allergy. - **IV to oral switch**: After clinical improvement. - **Analgesia/anti-emetics**: Offer as needed; paracetamol safe in early pregnancy. **Patient Advice**: Rest, abstain from sex until treatment completion, avoid alcohol with metronidazole, and adhere to follow-up. **Complications & Follow-up**: Discuss long-term sequelae (e.g., infertility); refer for monitoring. Ensure partner notification and STI testing. **Pregnancy Considerations**: Most antibiotics (e.g., ceftriaxone, azithromycin) are safe; limited data for metronidazole/ofloxacin. IUCD removal debated. **Compliance**: Training and protocol adherence are critical for effective management\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T22-20-22",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"gp003-pelvic-inflammatory-disease-pid-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 3207\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Pelvic Inflammatory Disease Management Protocol\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"NICE\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"2004\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Pelvic Inflammatory Disease (PID) Protocol: GP003** **Definition & Epidemiology**: PID is an ascending infection from the endocervix, causing inflammation of pelvic organs. Incidence is likely underestimated and increasing due to rising STIs. **Pathogens**: Commonly caused by *Chlamydia trachomatis*, *Neisseria gonorrhoeae*, anaerobes, and *Mycoplasma*. **Diagnosis**: - Clinical features: Lower abdominal pain, dyspareunia, abnormal bleeding/discharge, tenderness, fever. - Testing: Screen for gonorrhoea/chlamydia; consider urinalysis, blood tests, swabs, and pelvic ultrasound. **Management**: - **Antibiotics**: Broad-spectrum regimens (outpatient or inpatient), adjusted for pregnancy and penicillin allergy. - **IV to oral switch**: After clinical improvement. - **Analgesia/anti-emetics**: Offer as needed; paracetamol safe in early pregnancy. **Patient Advice**: Rest, abstain from sex until treatment completion, avoid alcohol with metronidazole, and adhere to follow-up. **Complications & Follow-up**: Discuss long-term sequelae (e.g., infertility); refer for monitoring. Ensure partner notification and STI testing. **Pregnancy Considerations**: Most antibiotics (e.g., ceftriaxone, azithromycin) are safe; limited data for metronidazole/ofloxacin. IUCD removal debated. **Compliance**: Training and protocol adherence are critical for effective management\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}